Skip to content

EyePoint, Inc. EYPT Net Investment in Lease

Net Investment in Lease at other companies

Ocular Therapeutix logo
Ocular TherapeutixOCUL
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
HRO
HarrowHROW
Theravance Biopharma logo
Theravance BiopharmaTBPH
LQD
Liquidia CorporationLQDA
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's net investment in lease?
EyePoint, Inc. (EYPT) reported net investment in lease of $19.78M in Q1 2026.
How has EyePoint, Inc. 's net investment in lease changed year-over-year?
EyePoint, Inc. 's net investment in lease decreased by 8.1% year-over-year, from $21.51M to $19.78M.
What is the long-term trend for EyePoint, Inc. 's net investment in lease?
Over 5 years (2020 to 2025), EyePoint, Inc. 's net investment in lease has grown at a 50.6% compound annual growth rate (CAGR), from $2.61M to $20.22M.